• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019新型冠状病毒感染会引发急性和/或慢性涎腺炎吗?

Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?

作者信息

Wang Chenxing, Wu Heming, Ding Xu, Ji Huan, Jiao Pengfei, Song Haiyang, Li Sheng, Du Hongming

机构信息

Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210029, PR China; Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, Jiangsu Province 210029, PR China.

Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu Province 210029, PR China; Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, Jiangsu Province 210029, PR China.

出版信息

Med Hypotheses. 2020 Apr 24;140:109789. doi: 10.1016/j.mehy.2020.109789.

DOI:10.1016/j.mehy.2020.109789
PMID:32361098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194735/
Abstract

2019 novel coronavirus (2019-nCoV) is widespread in China and other countries. The target of 2019-nCoV and severe acute respiratory syndrome coronavirus (SARS-CoV) is angiotensin-converting enzyme 2 (ACE2) positive cells. ACE2 is present in the salivary gland duct epithelium, and thus it could be the target of 2019-nCoV and SARS-CoV. SARS-CoV-related animal model experiments show that it can infect the epithelial cells on the salivary gland duct in Chinese rhesus macaques by targeting ACE2. Clinical studies confirmed that 2019-nCoV and SARS-CoV could be detected in saliva of human patients. We hypothesize that the infection of 2019-nCoV and SARS-CoV will lead to inflammatory pathological lesions in patients' target organs, and possibly inflammatory lesions in salivary glands. 2019-nCoV may cause acute sialoadenitis in the acute phase of infection. After the acute phase, chronic sialoadenitis may be caused by fibrosis repairment. Although there was no direct evidence to prove this, the available indirect evidence indicates a high probability of our hypothesis.

摘要

2019新型冠状病毒(2019-nCoV)在中国及其他国家广泛传播。2019-nCoV和严重急性呼吸综合征冠状病毒(SARS-CoV)的靶标是血管紧张素转换酶2(ACE2)阳性细胞。ACE2存在于唾液腺导管上皮中,因此它可能是2019-nCoV和SARS-CoV的靶标。与SARS-CoV相关的动物模型实验表明,它可以通过靶向ACE2感染中国恒河猴唾液腺导管上的上皮细胞。临床研究证实,在人类患者的唾液中可检测到2019-nCoV和SARS-CoV。我们推测,2019-nCoV和SARS-CoV的感染将导致患者靶器官出现炎性病理损伤,唾液腺也可能出现炎性损伤。2019-nCoV可能在感染急性期引起急性涎腺炎。急性期过后,纤维化修复可能导致慢性涎腺炎。虽然没有直接证据证明这一点,但现有的间接证据表明我们的推测很有可能成立。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b30/7194735/4baf3bd88901/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b30/7194735/4baf3bd88901/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b30/7194735/4baf3bd88901/gr1_lrg.jpg

相似文献

1
Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?2019新型冠状病毒感染会引发急性和/或慢性涎腺炎吗?
Med Hypotheses. 2020 Apr 24;140:109789. doi: 10.1016/j.mehy.2020.109789.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
5
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Systemic Inflammatory Response Syndrome全身炎症反应综合征
8
Remdesivir for the treatment of COVID-19.瑞德西韦治疗 COVID-19。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.
9
Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.放疗后预防口干和唾液腺功能障碍的药物干预措施。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD012744. doi: 10.1002/14651858.CD012744.
10
Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review.SARS-CoV-2 及其进入口腔组织和细胞的因素的存在:系统评价。
Medicina (Kaunas). 2021 May 23;57(6):523. doi: 10.3390/medicina57060523.

引用本文的文献

1
Comparative analysis of candidal carriage rates in long-term and short-term COVID-19 patients: An RT-PCR study.长期和短期新冠肺炎患者念珠菌携带率的比较分析:一项逆转录聚合酶链反应研究
J Oral Biol Craniofac Res. 2025 Jul-Aug;15(4):899-904. doi: 10.1016/j.jobcr.2025.06.014. Epub 2025 Jun 16.
2
Oral condition of patients hospitalized for Covid-19 and its impact on quality of life.因新冠病毒疾病住院患者的口腔状况及其对生活质量的影响。
Braz Oral Res. 2025 Feb 3;39:e009. doi: 10.1590/1807-3107bor-2025.vol39.009. eCollection 2025.
3
Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.

本文引用的文献

1
Consistent Detection of 2019 Novel Coronavirus in Saliva.唾液中 2019 新型冠状病毒的持续检测。
Clin Infect Dis. 2020 Jul 28;71(15):841-843. doi: 10.1093/cid/ciaa149.
2
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.2019 年新型冠状病毒疫情的公共卫生初始应对和临时临床指导-美国,2019 年 12 月 31 日至 2020 年 2 月 4 日。
MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1.
3
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
干燥综合征唾液腺纤维化发病机制中的免疫和非免疫介质。
Front Immunol. 2024 Oct 14;15:1421436. doi: 10.3389/fimmu.2024.1421436. eCollection 2024.
4
Submandibular Gland Pathogenesis Following SARS-CoV-2 Infection and Implications for Xerostomia.感染 SARS-CoV-2 后下颌下腺的发病机制及其对口干症的影响。
Int J Mol Sci. 2024 Jun 21;25(13):6820. doi: 10.3390/ijms25136820.
5
Frequency of Oral Lesions, Olfactory, and Gustatory Disorders and Xerostomia in Patients with COVID-19.新型冠状病毒肺炎患者口腔病变、嗅觉和味觉障碍及口干症的发生率
Dent J (Basel). 2024 Jun 11;12(6):179. doi: 10.3390/dj12060179.
6
Oral symptoms potentially associated with mild-to-moderate COVID-19 in tobacco users.烟草使用者中与轻至中度新冠肺炎潜在相关的口腔症状。
Tob Induc Dis. 2024 May 13;22. doi: 10.18332/tid/186531. eCollection 2024.
7
Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders.新型冠状病毒肺炎相关味觉和唾液分泌障碍的治疗
Dent J (Basel). 2023 May 25;11(6):140. doi: 10.3390/dj11060140.
8
Deciphering the role of Saliva in COVID 19: A global cross-sectional study on the knowledge, awareness and perception among dentists.解读唾液在 COVID-19 中的作用:一项针对全球牙医的知识、意识和看法的横断面研究。
BMC Oral Health. 2023 Jun 26;23(1):424. doi: 10.1186/s12903-023-03152-2.
9
Oral Changes in Hospitalized COVID-19 Patients: A Cross-Sectional Multicentric Study.住院COVID-19患者的口腔变化:一项横断面多中心研究。
Int J Dent. 2023 May 15;2023:3002034. doi: 10.1155/2023/3002034. eCollection 2023.
10
Oral health related quality of life and the prevalence of ageusia and xerostomia in active and recovered COVID-19 Patients.口腔健康相关生活质量以及活动期和恢复期 COVID-19 患者味觉丧失和口干的患病率。
PeerJ. 2023 Mar 6;11:e14860. doi: 10.7717/peerj.14860. eCollection 2023.
从过去中学习:针对 2019-nCoV 引起的严重急性呼吸道感染的可能紧急预防和治疗选择。
Chembiochem. 2020 Mar 2;21(5):730-738. doi: 10.1002/cbic.202000047. Epub 2020 Feb 25.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别:基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.
6
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例,提示存在人际传播:一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
9
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.新型冠状病毒持续的2019 - nCoV疫情对全球健康构成威胁——中国武汉最新的2019新型冠状病毒爆发。
Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.
10
The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration.马雷斯汀在炎症性疼痛中的作用:巨噬细胞在创伤再生中的功能。
Int J Mol Sci. 2019 Nov 21;20(23):5849. doi: 10.3390/ijms20235849.